Opportunities for Enhanced Communication between Manufacturers and US Payers (Part 3)
In part three of our series, ‘Opportunities for Enhanced Communication between Manufacturers and US Payers’, our experts explore the tools manufacturers can use to communicate HCEI to payers, insights from the Food and Drug Administration (FDA) guidance on payer communications, and practical considerations to optimize these interactions.
View
Feb 6, 2023
